<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01414322</url>
  </required_header>
  <id_info>
    <org_study_id>KSI-IL-HHZ-ER-01</org_study_id>
    <nct_id>NCT01414322</nct_id>
  </id_info>
  <brief_title>Documentation of Continuous Wheeze and Cough Dynamics in Pediatric ER SOB Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>KarmelSonix Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>KarmelSonix Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phenotype characterization of shortness of breath of pediatric emergency room patients by
      objective wheeze and cough monitoring improves diagnostic and severity assessment accuracy
      and correlates with overall patient outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>increase or decrease of WheezeRate (the proportion of wheezing in the respiratory cycle)</measure>
    <time_frame>Duration (from beginning to end) of emergency department stay. On average, 3 hours.</time_frame>
    <description>Characterize the dynamic pattern of wheeze rate (increase or decrease by 50% or unchanged) within 30 minutes of onset of therapy, and to correlate pattern to clinical diagnoses, severity assessment (accessory muscle use, oxygen saturation, inspiratory/expiratory ratio, severity of wheezing), and outcome (admission versus discharge).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>cough count (increase or decrease by more then 1 cough event or unchanged) in response to treatment</measure>
    <time_frame>Duration (from beginning to end) of emergency department stay. On average, 3 hours.</time_frame>
    <description>cough count (increase or decrease by more then 1 cough event or unchanged) in response to treatment and to correlate pattern to clinical diagnoses, severity assessment (accessory muscle use, oxygen saturation, inspiratory/expiratory ratio, severity of wheezing), and outcome (admission versus discharge).</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Asthma</condition>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Group 1: Patients ages 0 - 3</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Patients ages 3 - 7</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3: Patients ages 7 - 15</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric emergency room patients ages 0 - 15 with shortness of breath upon arrival at the
        hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient is admitted to the ER with shortness of breath

          -  patient management is according to standardized protocols used in Hadassah Mt. Scopus
             pediatric emergency department including:

               -  asthma management protocol

               -  bronchiolitis management protocol

          -  ages 0 - 15

          -  patient's parent/guardian is able to comprehend and give informed consent for
             participating in the study

        Exclusion Criteria:

          -  patient has received any dose of inhaled bronchodilators in the hour prior to
             enrollment

          -  patient has received oral or IV steroids in a time window of 30 minutes to 5 hours
             prior to enrollment

          -  ventilated patients, while ventilated

          -  chest skin lesions

          -  cystic fibrosis

          -  hemodynamic instability

          -  patient's parent/guardian objects to the study protocol

          -  concurrent participation in any other clinical study

          -  physician objection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eitan Kerem, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Center Mt. Scopus, Jerusalem, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Noam Gavriely, MD PhD</last_name>
    <phone>+972 54 466 1337</phone>
    <email>noam@karmelsonix.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ezekiel Balouka, MSc</last_name>
    <phone>+972 52 312 1098</phone>
    <email>ezekiel@karmelsonix.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hadassah Medical Center Mt. Scopus</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Eitan Kerem, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2011</study_first_submitted>
  <study_first_submitted_qc>August 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2011</study_first_posted>
  <last_update_submitted>August 10, 2011</last_update_submitted>
  <last_update_submitted_qc>August 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2011</last_update_posted>
  <responsible_party>
    <name_title>Noam Gavriely, MD PhD</name_title>
    <organization>KarmelSonix Ltd.</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

